Product Sheet

More information at http://www.biomarketgroup.com/market-research-report/the-indian-pharmaceutical-market-

outlook-to-2014-market-trends-key-players-forecast.html

The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players,
forecast
Published: 2009-JUN-26
Pages: 142
Format: PDF
Price: 3835 USD

Description
The Indian Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Indian pharmaceutical market,
incorporating the market structure, pricing and regulation and detailed analyses of the leading companies and likely
healthcare reforms. The report makes a wide-ranging assessment of the marketed product portfolios, R&D pipelines,
market share data, sales forecast and competitive landscape of the major players in the Indian market. Furthermore, it
highlights the key market and R&D trends that may influence treatment sales, with a thorough analysis of the competitive
dynamics of leading brands within the country and across different indications, in order to enable the reader to identify
growth trends, key drug classes and leading players through to 2014.

Table of Contents
The Indian Pharmaceutical Market Outlook to 2014
Executive summary 10
Overview of India 10
The Indian healthcare system 11
The pharmaceutical industry in India 12
Key players in the Indian pharmaceutical market 13
Indian pharmaceutical market SWOT analysis 14
Chapter 1 Scope and methodology 16
Scope 16
Methodology 16
Scope of IMS data 17
Chapter 2 Overview of India 20
Summary 20
Introduction 21
Overview of Indian history 21
The government 21
A burgeoning economy 22
Key economic parameters 23
An imprint of the global slowdown 24
Population profile and demographic trends 26
Disease burden 27
Vector-borne diseases 31
Chapter 3 The Indian healthcare system 34
Summary 34
Introduction 35
Healthcare system 37
The rural healthcare system 38
The urban healthcare system 39
Specialist and emergency medical care 40
The regulatory set-up 41
Intellectual property rights 41
Effect of IPR regime on innovation 42
Financing healthcare 43
Inefficiencies fueled by underutilization of funds 45
Pricing and reimbursement 46
Private health insurance 47
Private healthcare 49
A range of private healthcare services 50
Public-private partnerships 50
Alternative medicine: AYUSH 51
Ayurveda 51
Yoga 52
Naturopathy 52
Unani 52
Siddha 53
Homoeopathy 53

http://ww.biomarketgroup.com
BioMarket Group - A Global Online Aggregator of Life Science Market Research
Chapter 4 The pharmaceutical market in India 56
Summary 56
Introduction 57
Key market trends, events and issues 59
Therapy area analysis 64
Therapy area sales forecast 74
Leading brands 75
Leading brands sales forecast 79
Over-the-counter medication 80
The Indian generics advantage 80
Chapter 5 Key players in the Indian pharmaceutical market 84
Summary 84
Introduction 85
Leading players of the Indian pharmaceutical market 86
Detailed analysis of the Indian pharmaceutical market players 87
Cipla 87
Overview 87
Sales focus by leading drug classes 88
Sales focus by leading brands 91
New product launches 92
SWOT analysis 94
Strengths 94
Weaknesses 95
Opportunities 96
Threats 96
Ranbaxy 97
Overview 97
Sales focus by leading drug classes 97
Sales focus by leading brands 99
R&D pipeline analysis 101
SWOT analysis 103
Strengths 103
Weaknesses 104
Opportunities 105
Threats 106
GlaxoSmithKline (India) 106
Overview 106
Sales focus by leading drug classes 107
Sales focus by leading brands 108
R&D pipeline analysis 111
SWOT analysis 112
Strengths 112
Weaknesses 113
Opportunities 113
Threats 115
Piramal Healthcare 115
Overview 115
Sales focus by leading drug classes 115
Sales focus by leading brands 117
R&D pipeline analysis 119
SWOT analysis 120
Strengths 120
Weaknesses 122
Opportunities 122
Threats 123
Zydus Cadila 123
Overview 123
Sales focus by leading drug classes 124
Sales focus by leading brands 125
R&D pipeline analysis 126
SWOT analysis 127
Strengths 127
Weaknesses 128
Opportunities 128
Threats 129
A snapshot of other key market players 129
Sun Pharma 129
Lupin 130
Alkem 131
Sanofi-Aventis 132
Mankind Pharma 133
Leading players in the Indian pharmaceutical market: sales forecast 134
Chapter 6 Appendix 136
IMS data 136
Anatomical Therapeutic Classification (ATC) 136
A: Alimentary tract and metabolism 136

http://ww.biomarketgroup.com
BioMarket Group - A Global Online Aggregator of Life Science Market Research
B: Blood and blood-forming organs 136
C: Cardiovascular system 136
D: Dermatologicals 137
G: Genito-urinary system and sex hormones 137
H: Systemic hormonal preparations 137
J: General anti-infectives systemic 137
L: Antineoplastic and immunomodulating agents 137
M: Musculo-skeletal system 137
N: Nervous system 138
R: Respiratory system 138
S: Sensory organs 138
T: Diagnostic agents 138
V: Various 138
Glossary 139
Index 141
List of Figures
Figure 1.1: Indian pharmaceutical market SWOT analysis 14
Figure 2.2: Real GDP growth rate at factor cost across different quarters of the fiscal years 2008
and 2009 (%) 24
Figure 2.3: Comparative position ($bn) of India among the top service exporters globally, 2007 25
Figure 2.4: Deaths by cause for non-communicable diseases in India, 2005 28
Figure 3.5: Total expenditure on health per capita ($) in seven emerging pharmaceutical markets, 2006 36
Figure 3.6: Rural healthcare network in India 39
Figure 3.7: Public spending on healthcare (% GDP) in India, 1950-2006 44
Figure 4.8: Comparative position of India among the different global markets, 2008 58
Figure 4.9: Top 10 drug classes of the alimentary tract and metabolism therapy area ($m), 2008 66
Figure 4.10: Top 10 drug classes of the anti-infective therapy area ($m), 2008 68
Figure 4.11: Top 10 drug classes of the cardiovascular system therapy area, ($m) 2008 69
Figure 4.12: Top 10 drug classes of the respiratory system therapy area ($m), 2008 70
Figure 4.13: Top 10 drug classes of the nervous system therapy area ($m), 2008 72
Figure 4.14: Therapy area sales growth trend, 2004–08 73
Figure 5.15: Market share of leading players in the Indian pharmaceutical market (%), 2008 86
Figure 5.16: Cipla's Indian market sales by therapy area ($m), 2008 89
Figure 5.17: Cipla's SWOT analysis 94
Figure 5.18: Ranbaxy's Indian market sales by therapy area ($m), 2008 98
Figure 5.19: Ranbaxy's SWOT analysis 103
Figure 5.20: GSK's Indian market sales by therapy area ($m), 2008 107
Figure 5.21: GSK (India) SWOT analysis 112
Figure 5.22: Piramal Healthcare's Indian market sales by therapy area ($m), 2008 116
Figure 5.23: Piramal Healthcare's SWOT analysis 120
Figure 5.24: Zydus Cadila's Indian market sales by therapy area ($m), 2008 124
Figure 5.25: Zydus Cadila's SWOT analysis 127
List of Tables
Table 2.1: Political snapshot of India 22
Table 2.2: Economic snapshot of India 23
Table 2.3: Demographic snapshot of India 26
Table 2.4: Ten leading causes of death (%) in India, 2002 27
Table 2.5: Forecast epidemiology of major diseases in India, 2008–14 29
Table 2.6: Vector-borne diseases in India 31
Table 4.7: Indian pharmaceutical market by therapy area sales, 2008 65
Table 4.8: Indian pharmaceutical market therapy area sales forecast ($m), 74
Table 4.9: Indian pharmaceutical market by leading brands, 2008 75
Table 4.10: Top 10 brands of the Indian pharmaceutical market, sales forecast 2008–14 79
Table 5.11: Leading players of the Indian pharmaceutical market by sales, 2008 87
Table 5.12: Cipla’s leading brands in the Indian market (($m), 2008 91
Table 5.13: Leading recently launched products of Cipla in the Indian market 93
Table 5.14: Leading brands of Daiichi-Ranbaxy in the Indian market ($m), 2008 100
Table 5.15: Leading pipeline compounds of Ranbaxy in the Indian market 102
Table 5.16: Leading brands of GSK in the Indian market, 2008 109
Table 5.17: Key patented products of GSK launched in India 114
Table 5.18: Leading brands of Piramal Healthcare in the Indian market, 2008 118
Table 5.19: Piramal Healthcare's key acquisitions 121
Table 5.20: Piramal Healthcare's key alliances and licensing agreements 122
Table 5.21: Leading brands of Zydus Cadila in the Indian market, 2008 125
Table 5.22: Key pipeline drugs for Zydus Cadila 126
Table 5.23: Leading players in the Indian pharmaceutical market, sales forecast 2008–14 134

Ordering
Order Online - http://www.biomarketgroup.com/market-research-report/the-indian-
pharmaceutical-market-outlook-to-2014-market-trends-key-players-forecast.html

Order by Fax - using the form below

http://ww.biomarketgroup.com
BioMarket Group - A Global Online Aggregator of Life Science Market Research

Order by Post - print the order form below and send to:
BioMarket Group
Björnnäsvägen 21
11419 STOCKHOLM
SWEDEN

http://ww.biomarketgroup.com
BioMarket Group - A Global Online Aggregator of Life Science Market Research

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed
form to +46-8-56849191. If you have any questions please visit
http://www.biomarketgroup.com/index.php/contacts/

Order Information
Please verify that the product information is correct:

Product Name: The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast
Web Address: http://www.biomarketgroup.com/market-research-report/the-indian-pharmaceutical-market-outlook-to-2014-
market-trends-key-players-forecast.html
Format: PDF
Price: 3835 USD (Single User License)

Delivery of hard copy or CD-ROM is subject to a Courier charge of 50 USD.

Delivery within Sweden is subject to VAT at 25%.
Contact Information Payment Information
Please enter all the information below in BLOCK CAPITALS Please indicate the payment method you would like to use
by selecting the appropriate box.
Title:
Pay by credit card:
Name: American Express
Master Card
Email Address:* Visa
Cardholder Name:
Job Title:
Expiry Date (MM/YY):
Organization:
Card Number:
EU companies must supply: VAT / BTW / MOMS
MWST / IVA / FPA number: CVV Number:

Pay by check:
Address: Please post the check, accompanied by this form, to:
BioMarket Group
Zip Code: Björnnäsvägen 21
11419 STOCKHOLM
City: SWEDEN

State: Pay by wire transfer: Please transfer funds to:

Country: Account number: 43521169

Swift code: HANDSESS
Phone Number: IBAN number: SE74 6000 0000 0000 4352 1169
Bank Address: Handelsbanken, Stockholm, Sweden
Fax Number:
If you have a Marketing Code please enter it below:
Marketing Code:

Please supply purchase order number if needed:

* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, Gmail)

Please note that by ordering from BioMarket Group you are agreeing to our Terms and Conditions at
http://www.biomarketgroup.com/index.php/biomarket-group-full-terms-and-conditions

Please fax this form to: +46-8-56849191

http://ww.biomarketgroup.com